Micron Tech and Nike among market cap stock movers on Wednesday

Silicon Valley Acquisition Corp. completed its initial public offering of 20 million units at $10.00 per unit on December 24, 2025, raising $200 million in gross proceeds before underwriting fees and expenses.

The units began trading on the Nasdaq Global Market under ticker symbol "SVAQU" on December 23, 2025. Each unit contains one Class A ordinary share and one-half of one redeemable warrant. Each full warrant allows the holder to purchase one Class A ordinary share at $11.50 per share.

The Class A ordinary shares and warrants are expected to trade separately on Nasdaq under symbols "SVAQ" and "SVAQW" respectively once separate trading begins.

Silicon Valley Acquisition Corp. is a special purpose acquisition company formed to pursue mergers, acquisitions or business combinations. The company stated it intends to focus on target businesses in fintech, cryptocurrency and digital assets, AI-driven infrastructure, energy transition, automotive and mobility, technology, consumer, healthcare and mining industries.

Clear Street LLC served as lead book-running manager for the offering. The underwriters received a 45-day option to purchase up to 3 million additional units at the offering price to cover over-allotments.

The Securities and Exchange Commission declared the registration statement for the securities effective on December 22, 2025, according to the company’s statement.

Investing.com -- Biohaven Ltd. (NYSE:BHVN) stock dropped 11.8% in after-hours trading Wednesday following the company’s announcement that its depression drug candidate failed to meet the primary goal in a Phase 2 trial.

The clinical-stage biopharmaceutical company reported that BHV-7000 did not achieve a statistically significant reduction in depressive symptoms compared to placebo in patients with major depressive disorder (MDD). The study measured changes in the Montgomery Åsberg Depression Rating Scale (MADRS) over a six-week period.

Despite the disappointing primary results, Biohaven noted some positive trends in specific subgroups, particularly among patients with more severe depression at screening and baseline. The company described these subgroup analyses as "hypothesis generating" but stated it would not pursue additional psychiatric clinical trials with BHV-7000.

"Although the results of this study do not support the efficacy of BHV-7000 in a broad population of depressed patients, we appreciate the commitment of the patients, investigators, and study teams who have advanced the field assessing new therapeutic approaches and made this important research possible," said Ahmed Tahseen, MD, Development Lead for Depression at Biohaven.

The drug demonstrated a favorable safety profile, with adverse events mostly mild to moderate and resolving spontaneously. Headache was reported in 10.7% of BHV-7000 patients versus 9.9% in the placebo group, while nausea occurred in 4.2% of treated patients compared to 5.6% on placebo.

Biohaven indicated it would prioritize its resources on key areas including immunology, obesity, and epilepsy programs through 2026. The company plans to present additional analyses from the depression study at an upcoming scientific meeting.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com-- The S&P 500 clinched another record high close Wednesday in a holiday-shortened trading day as the Santa rally continued.

At 1:00 p.m. ET (18:00 GMT), S&P 500 was rose 0.3% to a fresh closing record of 6,932.05, and NASDAQ Composite rose 0.6%. Dow Jones Industrial Average was up xx points, or 0.2%.

U.S. stock markets closed early at 1 p.m. ET, with bond markets shutting an hour later. All markets will be closed on Thursday for Christmas Day and are set to reopen for regular trading on Friday.

Wall St gains on strong Q3 GDP; Nike jumps as Apple CEO Tim Cook doubles stake 

Wall Street ended the regular session higher. The S&P 500 climbed about 0.5% to a record closing high, supported by gains in technology and growth stocks, while the NASDAQ Composite gained 0.6% and the Dow Jones Industrial Average added 0.2%.

Investors took encouragement from data showing the U.S. economy grew at a robust pace in the third quarter. Gross domestic product expanded at an annualised rate of 4.3%, surpassing expectations.

While the strong reading briefly pushed Treasury yields higher, equity markets appeared largely unfazed, with traders viewing the data as backward-looking and unlikely to derail the broader policy outlook.

Markets are also entering the period often referred to as the “Santa Claus rally,” a seasonal phenomenon describing the tendency for U.S. stocks to rise during the final five trading days of December and the first two sessions of January.

So far, gains this week have kept that seasonal narrative intact.

Despite the solid growth data, expectations that the Federal Reserve will eventually ease monetary policy remain largely unchanged. Interest-rate futures indicate traders still anticipate rate cuts in 2026 amid a resilient economy and sticky inflation pressures.

Nike Inc (NYSE:NKE), meanwhile, rose more than 4% after Apple CEO Tim Cook doubled his stake in athleisure wear brand to 105,000 shares as of Dec. 22. Cook has been on the board of Nike since 2005.

UiPath Inc (NYSE:PATH) was also in rally mode, rising more than 7% as the automation platform is set to be added to the S&P MidCap 400 on Jan 2, replacing Synovus Financial.

(Ayushman Ojha contributed to this report.)

Investing.com -- Snowflake Inc. (NYSE:SNOW) stock fell 1.4% Wednesday following an article from The Information reporting that the data cloud company is in discussions to acquire app monitoring startup Observe Inc. for approximately $1 billion, which would mark Snowflake’s largest acquisition to date.

The potential deal would expand Snowflake’s capabilities into the observability tools market, allowing it to compete more directly with established players like Datadog (NASDAQ:DDOG) and Cisco’s (NASDAQ:CSCO) Splunk. Observe’s technology helps developers monitor application performance and identify disruptions and outages.

Observe already maintains close ties with Snowflake, utilizing the company’s database technology for its operations. Snowflake’s venture arm invested in Observe earlier this year, and Observe CEO Jeremy Burton currently serves as a director on Snowflake’s board. Both companies also share a board member in Mike Speiser of Sutter Hill Ventures.

Founded in 2018, Observe has raised over $470 million from investors including Sutter Hill Ventures and Madrona Ventures, reaching a valuation of $848 million in its most recent funding round, according to PitchBook.

Baird analyst William Power, who maintains an Outperform rating and $270 price target on Snowflake, noted that while the rumored price tag would represent Snowflake’s biggest acquisition, it "should still be fairly digestible given the company’s current balance sheet ($4.4 billion of cash and $2.1 billion of net cash at FQ3-end) and FCF generation."

The acquisition would follow Snowflake’s purchase of TruEra AI last year, an observability startup focused on monitoring AI application performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- The National Highway Traffic Safety Administration (NHTSA) has opened a probe into Tesla Model 3 emergency door releases following a petition from a Georgia owner.

The investigation, opened Monday, focuses on claims that the mechanical door release in certain Model 3 vehicles is "hidden, unlabeled, and not intuitive to locate during an emergency," according to NHTSA documents.

The probe was prompted by a petition filed by Kevin Clouse, who reported being trapped in his Tesla vehicle in 2023. Clouse requested a formal defect investigation into the issue.

NHTSA’s Office of Defects Investigation opened the defect petition (DP25002) to evaluate the claims and determine whether to grant or deny the request. The agency has not yet made a decision on the petition.

The investigation covers an estimated 179,071 model year 2022 Tesla (NASDAQ:TSLA) Model 3 vehicles.

According to NHTSA records, there has been one incident report related to this issue, which involved both an injury and a crash. The petition itself was filed on November 24, 2025, and can be reviewed on the NHTSA website under ODI number 11698174.

This is not the first time Tesla’s door handles have faced regulatory scrutiny.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Energy drink stocks continue to deliver strong performance in 2025, offering investors exposure to one of the beverage industry’s most dynamic segments. According to WarrenAI’s analysis using Investing Pro metrics, several key players stand out ahead of 2026 for their growth potential and market positioning.

Compare WarrenAI and Wall Street analysts using InvestingPro -

The energy drink market remains robust with continued consumer demand for functional beverages that provide performance benefits. Using a comprehensive evaluation of fair value estimates, Pro scores, technical indicators, and analyst price targets, we’ve identified the top performers in this competitive space.

1. Monster Beverage Corporation (NASDAQ:MNST)

Monster maintains its position as the blue-chip leader in the energy drink sector, recently reaching a new 52-week high with a 47.9% one-year return. Despite trading at a premium forward P/E of 38.9x and showing a -12.1% fair value downside according to InvestingPro, Monster’s exceptional financial health (Pro Score:3.43) and strong ROIC of 22.1% justify its position. Analysts maintain support with a mean price target of $76.05, while technical indicators show strong momentum on both daily and weekly timeframes. The company’s global expansion and innovation pipeline continue to drive its market leadership.

In recent news, Monster Beverage has received several price target increases from analyst firms, including Stifel, Piper Sandler, and Wells Fargo, which pointed to the company’s growth outlook and innovation in zero-sugar products.

2. Celsius Holdings Inc (NASDAQCM:CELH)

Celsius represents the high-growth contender in the energy drink space, delivering an impressive 63.0% annual return. With projected revenue growth of 79.6% for FY2025 and a fair value upside of 16.6%, the company shows significant potential. However, investors should note the volatility associated with its growth trajectory, particularly following transition-related challenges with the Alani Nu brand’s move to Pepsi. While technical indicators remain bullish, Celsius’s forward P/E of 35.4x reflects high expectations that require continued execution.

Celsius Holdings recently announced a new $300 million share repurchase program. The company also saw Piper Sandler lower its price target to $61, while UBS reiterated its Buy rating.

3. GURU Organic Energy Corp (TSX:GURU)

GURU Organic Energy has been the standout performer with an extraordinary 292.8% one-year return, making it the speculative darling of the sector. However, its Pro Score of 2.12 signals weaker financial health compared to industry leaders, with concerning metrics including a negative free cash flow yield of -18.5%. With minimal fair value upside remaining (0.1%), investors should approach with caution despite analyst targets suggesting room for growth to C$6.00.

GURU Organic Energy Corp was downgraded to Hold from Buy by Stifel Canada, which noted the stock’s significant price surge as the reason for the change.

4. Suntory Beverage & Food Limited (OTCPK:STBF.Y)

Suntory presents a value opportunity within the energy drink space, currently trading at a more reasonable forward P/E of 17.5x with a substantial 29.6% fair value upside according to InvestingPro. Despite underperforming with a -5.6% one-year return, the company’s healthy 6.2% free cash flow yield and strong analyst consensus suggest potential for recovery. Investors seeking a more defensive position with value characteristics may find Suntory’s profile appealing as a contrarian play.

Suntory’s parent company, Suntory Holdings, announced that its Jim Beam brand plans to pause production at its main U.S. distillery for all of 2026 due to an oversupply of whiskey.

These companies represent different investment approaches within the energy drink sector, from established market leaders to high-growth challengers and value opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.